Biogen (BIIB) Tops Q1 EPS by 6c; cuts guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $209.83 -0.39%
Financial Fact:
Income tax expense: 337M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income tax expense: 337M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $3.02, $0.06 better than the analyst estimate of $2.96. Revenue for the quarter came in at $2.43 billion versus the consensus estimate of $2.23 billion.
GUIDANCE:
Biogen sees FY2025 EPS of $14.50-$15.50, versus the consensus of $15.20.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Full Circle Lithium closes $5.14M private placement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
